Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial

Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial

Abstract Introduction This prospective, multicenter, randomized, double-masked pivotal phase 3 trial evaluated the efficacy and safety of the travoprost intracameral SE-implant (slow-eluting implant, the intended commercial product) and FE-implant (fast-eluting implant, included primarily for maskin...

Full description

Bibliographic Details
Main Authors: Steven R. Sarkisian, Robert E. Ang, Andy M. Lee, John P. Berdahl, Sebastian B. Heersink, James H. Burden, Long V. Doan, Kerry G. Stephens, David Applegate, Angela C. Kothe, Dale W. Usner, L. Jay Katz, Tomas Navratil
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-02-01
Series:Ophthalmology and Therapy
Subjects:
iDose® TR
Intraocular pressure
Ocular drug delivery system
Ocular hypertension
Open-angle glaucoma
Travoprost intracameral implant
Online Access:https://doi.org/10.1007/s40123-024-00898-y

Internet

https://doi.org/10.1007/s40123-024-00898-y

Similar Items